Patent · US Active

C4-carbonothioate-substituted tryptamine derivatives and methods of using

US11845726B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2022
Grant dateDec 19, 2023
Priority date
Expiry dateAug 22, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.